Lipoxygenase interactions with natural flavonoid, quercetin, reveal a complex with protocatechuic acid in its X-ray structure at 2.1 Å resolution

被引:77
作者
Borbulevych, OY
Jankun, J
Selman, SH
Skrzypczak-Jankun, E
机构
[1] Med Coll Ohio, Urol Res Ctr, Dept Urol, Toledo, OH 43614 USA
[2] Med Coll Ohio, Dept Physiol & Mol Med, Toledo, OH 43614 USA
关键词
lipoxygenase; co-oxidase activity; lipoxygenase inhibitors; flavonoids; quercetin/metabolism/oxidative degradation;
D O I
10.1002/prot.10579
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
PUFA metabolites have a profound effect on inflammatory diseases and cancer progression. Blocking their production by inhibiting PUFA metabolizing enzymes (dioxygenases: cyclooxygenases and LOXs) might be a successful way to control and relieve such problems, if we learn to better understand their actions at a molecular level. Compounds with strong antioxidative and free radical scavenging properties, such as polyphenols, could be effective in blocking PUFA activities, and natural flavonoids possess such qualities. Quercetin belongs to the group of natural catecholic compounds and is known as a potent, competitive inhibitor of LOX. Structural analysis reveals that quercetin entrapped within LOX undergoes degradation, and the resulting compound has been identified by X-ray analysis as protocatechuic acid (3,4-dihydroxybenzoic acid) positioned near the iron site. Its C3-OH group points toward His523, C4-OH forms a hydrogen bond with O-C from the enzyme's C-terminus, and the carboxylic group is incorporated into the hydrogen bonding network of the active-site neighborhood via Gln514. This unexpected result, together with our previous observations concerning other polyphenols, yields new evidence about the metabolism of natural flavonoids. These compounds might be vulnerable to the co-oxidase activity of LOX, leading to enzyme-stimulated oxidative degradation, which results in an inhibitor of a lower molecular weight. (C) 2003 Wiley-Liss, Inc.
引用
收藏
页码:13 / 19
页数:7
相关论文
共 48 条
  • [1] CHELATING AND FREE-RADICAL SCAVENGING MECHANISMS OF INHIBITORY-ACTION OF RUTIN AND QUERCETIN IN LIPID-PEROXIDATION
    AFANASEV, IB
    DOROZHKO, AI
    BRODSKII, AV
    KOSTYUK, VA
    POTAPOVITCH, AI
    [J]. BIOCHEMICAL PHARMACOLOGY, 1989, 38 (11) : 1763 - 1769
  • [2] Applications of the Cambridge Structural Database in organic chemistry and crystal chemistry
    Allen, FH
    Motherwell, WDS
    [J]. ACTA CRYSTALLOGRAPHICA SECTION B-STRUCTURAL SCIENCE CRYSTAL ENGINEERING AND MATERIALS, 2002, 58 : 407 - 422
  • [3] The Cambridge Structural Database: a quarter of a million crystal structures and rising
    Allen, FH
    [J]. ACTA CRYSTALLOGRAPHICA SECTION B-STRUCTURAL SCIENCE, 2002, 58 (3 PART 1): : 380 - 388
  • [4] [Anonymous], ACTA CRYSTALLOGR D
  • [5] Fate of the flavonoid quercetin in human cell lines: Chemical instability and metabolism
    Boulton, DW
    Walle, UK
    Walle, T
    [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 1999, 51 (03) : 353 - 359
  • [6] *BRUK AXS INC, 2001, SHELXTL NT VERS 6 12
  • [7] New software for searching the Cambridge Structural Database and visualizing crystal structures
    Bruno, IJ
    Cole, JC
    Edgington, PR
    Kessler, M
    Macrae, CF
    McCabe, P
    Pearson, J
    Taylor, R
    [J]. ACTA CRYSTALLOGRAPHICA SECTION B-STRUCTURAL SCIENCE CRYSTAL ENGINEERING AND MATERIALS, 2002, 58 : 389 - 397
  • [8] Conklin Kenneth A, 2002, Altern Med Rev, V7, P4
  • [9] DANGLES O, 1999, J CHEM SOC P2, V7, P1387
  • [10] Datta K, 1997, DRUG METAB DISPOS, V25, P196